CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
by Impact Journals LLC(A) Immunohistochemistry (IHC) staining of testis (positive control). (B) IHC staining of colonic adenocarcinoma. (C) IHC stating of Normal colonic mucosa (negative control). Pur
Updated on: April 08,2024
18
CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
by Impact Journals LLC(A) Immunohistochemistry (IHC) staining of testis (positive control). (B) IHC staining of colonic adenocarcinoma. (C) IHC stating of Normal colonic mucosa (negative control). Pur
Updated on:April 08,2024
18